Credit Suisse’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,780
Closed -$27K 4608
2021
Q2
$27K Buy
+11,780
New +$26.5K ﹤0.01% 4417

Other funds holding ATIP.WS

Credit Suisse's ATIP.WS Position: Q3 2021 in Review

Credit Suisse sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q3 2021, closing a stake of 11,780 shares — an estimated $27K sold.

Credit Suisse first reported a position in ATIP.WS in Q2 2021 and held it in 1 quarter. The position peaked at $27K in Q2 2021. 20 funds tracked by Wall St. Rank hold ATIP.WS as of Q3 2021.

  • Credit Suisse reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • Credit Suisse sold 11,780 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $27K.
  • Credit Suisse first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • Credit Suisse's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $27K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.